Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk
CardioVascular and Interventional Radiology · 2023
DOI: 10.1007/s00270-023-03556-1 ↗Kurz gefasst
Editorial in der Zeitschrift CardioVascular and Interventional Radiology, 2023. Verfasst von Ulf Teichgräber. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germ…. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Angioplasty, Balloon, Peripheral Arterial Disease. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Jena.
Abstract (Originalsprache)
The IN.PACT Global real-world study on the treatment of femoropopliteal peripheral artery disease with paclitaxel drug-coated balloon (DCB) angioplasty revealed sustained effectiveness and safety. Freedom from target lesion revascularization (TLR) at 5 years was 69% and freedom from 5-year all-cause mortality was 79% [1]. Whether long-term outcomes in high-risk participants with diabetes or chronic limb-threatening ischemia (CLTI) differ from those without has now been evaluated in a post hoc analysis. Results are presented in this issue of CVIR, by Rei-jnen et al. [2]. Results from the previous IN.PACT SFA randomized controlled trial (RCT) [3] have likely been basis for this research issue. In the total cohort, DCB was superior to standard balloon angioplasty (PTA) (freedom from TLR: 75 and 65%, respectively, p = 0.02). However, with diabetes, a treatment effect that had been demonstrated at 2 years (primary patency) was no longer evident at 5 years (freedom from TLR: 70 and 64%, respectively, p = 0.243). Whether the latter
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany. ulf.teichgraeber@med.uni-jena.de.
ORCID-Profile: Ulf Teichgräber
Förderung
- Universitätsklinikum Jena
Zitieren
APA
Teichgräber, U. (2023). Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-023-03556-1
Vancouver
Teichgräber U. Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk. CardioVascular and Interventional Radiology. 2023. doi:10.1007/s00270-023-03556-1
BibTeX
@article{Teichgrber2023,
author = {Teichgräber, Ulf},
title = {Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk},
journal = {CardioVascular and Interventional Radiology},
year = {2023},
doi = {10.1007/s00270-023-03556-1}
}
EUVIMED